Bristol Myers Squibb CEO on cancer developments in the pipeline

Bristol Myers Squibb CEO Chris Boerner sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's annual meeting to discuss the company's latest cancer drug data, its $15 billion deal with China's Hengrui, and more.